KATHRYN HUHMANN: Open Payments
NPI 1760978464 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 25 payments from 10 companies in 2025. Trend: 2023 $1,008 · 2024 $749 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $165 |
| Boston Scientific Corporation | 1 | $153 |
| Sumitomo Pharma America, Inc. | 5 | $107 |
| Astellas Pharma US Inc | 4 | $103 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $83 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $75 |
| Laborie Medical Technologies Corp. | 2 | $43 |
| ABBVIE INC. | 2 | $27 |
| 180 Medical, Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $19 |
Products named: INTERSTIM, Axonics, Veozah, GEMTESA, MYFEMBREE, BOTOX, SLYND, EndoSheath Technology.
Industry payments across NE — which companies pay providers there.
